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MALDI imaging mass spectrometry (MALDI-IMS) has become a powerful tool for the
detection and localization of drugs, proteins, and lipids on-tissue. Nevertheless, this approach
can only perform identification of low mass molecules as lipids, pharmaceuticals, and
peptides. In this article, a combination of approaches for the detection and imaging of proteins
and their identification directly on-tissue is described after tryptic digestion. Enzymatic
digestion protocols for different kinds of tissues—formalin fixed paraffin embedded (FFPE)
and frozen tissues—are combined with MALDI-ion mobility mass spectrometry (IM-MS). This
combination enables localization and identification of proteins via their related digested
peptides. In a number of cases, ion mobility separates isobaric ions that cannot be identified by
conventional MALDI time-of-flight (TOF) mass spectrometry. The amount of detected peaks
per measurement increases (versus conventional MALDI-TOF), which enables mass and time
selected ion images and the identification of separated ions. These experiments demonstrate
the feasibility of direct proteins identification by ion-mobility-TOF IMS from tissue. The tissue
digestion combined with MALDI-IM-TOF-IMS approach allows a proteomics “bottom-up”
strategy with different kinds of tissue samples, especially FFPE tissues conserved for a long
time in hospital sample banks. The combination of IM with IMS marks the development of IMS
approaches as real proteomic tools, which brings new perspectives to biological studies. (J Am
Soc Mass Spectrom 2010, 21, 338–347) © 2010 American Society for Mass SpectrometryImaging mass spectrometry (IMS) is a mass spec-trometry technique applied to chemical analysis ofsurfaces. Ion beams for secondary ion mass spectrom-
etry (SIMS) [1–4] and lasers for matrix-assisted-laser-
desorption-ionization mass spectrometry (MALDI-MS)
[5–8] are commonly used surface probes for IMS, which
typically provide nanometer and micrometer lateral res-
olution, respectively. The application of IMS to the
analysis of biological surfaces and tissues has emerged
more recently [9–13]. The intrinsic label-free capabilities
of IMS allow the spatial distribution of each molecule
on the surface to be measured simultaneously by the
detection of its specific molecular weight. The chemical
and localization information obtained by IMS can be
compared with the results of immuno-histochemistry
(IHC) [14]. However, IMS is also a discovery-oriented
tool for nontargeted investigation of thousands of mol-
ecules in a single experiment [15]. IMS integrates natu-
rally into proteomics workflows for peptide and protein
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doi:10.1016/j.jasms.2009.09.016analysis and identification on-tissue, which has led to a
number of recent biological applications [16].
However, the potential of IMS integration into pro-
teomics field is still compromised by two issues: the
sensitivity of detection and the identification capabili-
ties of low abundant peptides are rather low compared
with other classic proteomics techniques. Between 1000
and 3000 molecules are usually detected and corre-
spond to the most abundant ionizable peptides. The
biological applications of IMS for peptides and proteins
mainly use MALDI-MS. The lateral resolution is limited
by the laser spot size rastering the surface (in micro-
probe mode). High-resolution MALDI-MS instruments,
such as stigmatic ion microscopes [17, 18], circumvent
this issue but the detection of full mass spectra can be
problematic, in most cases due to slow detectors (CCD
cameras, phosphor screens, or delay lines) [19]. The
majority of IMS experiments are performed in the micro-
probe MALDI-SIMS mode, where high spatial resolution
is limited by the loss of sensitivity and chemical damage
due to highly focused laser beams [20].
Therefore, one of the main concerns for IMS is
on-tissue detection sensitivity. Low sensitivity is caused
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analyte and the large chemical complexity of microen-
vironments, which is responsible for ion suppression
effects. Sample preparation methods play a crucial role
in enhancing sensitivity on-tissue [14, 21]. In addition,
instrumental sensitivity of TOF mass spectrometers
usually decreases at high m/z, which are currently the
most widespread instruments in use for IMS. These
limitations slow the development of on-tissue identifi-
cation, which is needed to make IMS a practical tool for
proteomics.
Sample preparation protocols, which include tissue
washes and careful matrix deposition, are used to
minimize ion suppression effects and enhance availabil-
ity of analytes at the surface. Specific protocols were
developed for both fresh-frozen and fixed tissues (typ-
ically formalin-fixation followed by paraffin embedding
FFPE) [22–24]. The analysis of FFPE tissue opens hos-
pital sample banks, which represent an enormous
amount of well documented tissues, whereas fresh
samples are sometimes more scarce. Other sample
preparation and instrumental strategies include, e.g.,
targeting chemical families with functionalized nano-
particles and development of post-ionization sources
[25–28].
A powerful complementary technique to direct pro-
tein analysis is on-tissue enzymatic digestion [22, 29–
31]. Protein digestion typically yields peptides between
400 and 3500 Da, a range where instrumental sensitivity
is higher than that for intact proteins. However, the
mass spectrum is more complicated in the low mass
region. In addition, enzymatic digestion enables effi-
cient tandem MS on small single charged peptides in
TOF-based instruments. Current approaches for identi-
fication of digested proteins or peptides from tissue
involve extraction and separate tandem-MS measure-
ments, sometimes followed by comparison with on-
tissue peptide mass fingerprinting (PMF) [29]. Tissue
chemical complexity prohibits efficient PMF. Further,
the mass resolving power and mass accuracy of TOF
instruments are usually insufficient for exact mass
detection of all measured intact proteins, though FT-MS
methods are available [32]. MS/MS has scarcely been
performed directly on-tissue; typically on the most
abundant peptides [30] or for disambiguation between
isobaric compounds rather than absolute identification
[33, 34]. However, the chemical complexity on-tissue
may result in multiple peptide ions at each nominal
mass. As a consequence, except for higher abundant
peptides, identification by MS/MS may prove difficult
due to fragments from different peptides.
Here we describe the combination of ion mobility
(IM) and ion mobility mass spectrometry (IMMS) to
separate the different peptide contributions to MS/MS
spectra from a single mass-selected peak [35–40]. IM
adds a separation dimension (reported as drift time) to
mass spectrometry, which is comparable to the reten-
tion time of liquid chromatography (LC) and gas chro-
matography (GC) hyphenated MS methods. Since itsinception in 1980s, ion mobility has evolved rapidly,
with the emergence of alternatives to the classic drift
tubes: field asymmetric waveform ion mobility spec-
trometry (FAIMS) and, these days, the traveling wave
(T-wave) [41, 42]. Initially, IM was used to differentiate
conformers in the gas phase, but more recently IMMS
has been applied to protein conformer differentiation,
top-down protein sequencing, noncovalent protein
complexes, isobaric compound identification, and im-
aging by mass spectrometry [43–46]. IM benefits IMS in
two major ways. First, the addition of a separation
dimension enables the detection of more MS peaks. IM
decongests the mass spectrum and allows the identifi-
cation of trends and chemical families, although, IM
does not enhance sensitivity since it does not modify
the ionization conditions. Secondly, the combination of
mass with drift time selection criteria enables the dif-
ferentiation of isobaric peptide contributions to a frag-
mentation spectrum. In this article, we present the high
sensitivity identification of multiple digested peptides
on-tissue with use of a MALDI-IM-IMS instrument
(SYNAPT-HDMS; Waters Corp., Manchester, UK), and
we show that IM-IMS enables the identification with
high sensitivity of numerous peptides on-tissue which
correspond to the additional step that was missing to the
actual incorporation of IMS into proteomic workflows.
Experimental
Materials and Methods
-Cyano-4-hydroxycinnamic acid (HCCA), 2,5 dihy-
droxibenzoic acid (2,5-DHB), ammonium bicarbonate,
trisma base, toluene, ethanol, angiotensin II, Des-Arg-
bradykinin, Substance P, ACTH 18-39, ACTH 7-38
(Adreno CorticoTropic Hormone), trifluoroacetic acid
(TFA)n and bovine insulin were obtained from Sigma-
Aldrich, (Zwijndrecht, The Netherlands) and used as
provided. Trypsin was purchased from Promega (Mad-
ison, WI, USA) and acetonitrile (ACN) and methanol
from Biosolve (Westford, MA, USA).
Animal Surgery and Tissue Preparation
Wistar male rats (180–200 g) were anesthetized with
pentobarbital (50 mg/kg, i.p.) and sacrificed. Their
brains were removed and fixed for 40 min at 48 °C in 4%
paraformaldehyde. Brain tissue blocks were stored in a
box at room temperature for 12 y before the experiments
described herein. Frozen human cerebellumwas provided
by EMC Rotterdam (Erasmus Medical Center). It was
fast-frozen with cold isopropane (50 °C) and directly
conserved in a 80 °C freezer for 1 mo before use.
Tissue Dewaxing and Treatment
Tissue sections of 10 m were obtained by microtome
(Microm HM 525; Walldorf, Germany) and applied to
340 STAUBER ET AL. J Am Soc Mass Spectrom 2010, 21, 338–347indium tin oxide (ITO) coated conductive glass slides.
Paraffin was removed by two baths of 5 min in toluene
and lightly rehydrated with graded ethanol (100°, 96°,
70°, and 30°) baths before drying at room temperature.
Frozen tissues were immerged in chloroform for 5 s
before use.
In Situ Trypsin Digestion and Matrix Deposition
Trypsin microspotting: spots of enzyme (trypsin at 0,05
g/L in water) were deposited by a high-accuracy
position automatic chemical inkjet printer (CHIP-1000;
Shimadzu Biotech, Kyoto, Japan). The whole tissue
section was microspotted with enzyme in a 150 m
spacing raster scheme. After optimization, the quantity
of trypsin was set to 20 nL deposited in 40 cycles of 500
pL at each spot position to cover the entire tissue
surface. HCCA matrix was deposited by a vibrational
sprayer system (ImagePrep; Bruker Daltonik GmbH,
Bremen, Germany). The matrix solution was HCCA (10
Figure 1. Workflow for FFPE or frozen on-tiss
steps of matrix deposition (b) on rat brain tiss
spectra of undigested (d) or digested (e) tissue are omg/mL) in ACN/TFA 0.1%, (6:4, vol/vol) and was
sonicated for 2 min.
Mass Spectrometry
MALDI MS and MSI Tissue Sections After In
Situ Automatic Trypsin Digestion
FFPE and frozen tissue section analysis after in situ
digestion was performed in an Ultraflex III TOF-TOF
instrument (Bruker Daltonik GmbH, Bremen, Ger-
many) and a Synapt MALDI-Q-ion mobility TOF (Wa-
ters Corp.). The Ultraflex is equipped with a LIFT III cell
and Smartbeam laser with a repetition rate up to 200
Hz. The Synapt is equipped with a YAG laser with a
repetition rate of 200 Hz and a T-wave ion mobility cell.
The ion mobility separation parameters were: trap gas
flow 1.5 mL/min (argon), IMS gas flow 22 mL/min
(nitrogen), and ion mobility wave velocity 300 m/s.
otein identification. The image shows the used
). After MALDI imaging experiment (c), massue pr
ue (abtained. Then images can be reconstructed (c).
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standard peptides (bradykinin 1.6 M, Substance P 1.6
M, ACTH 18-39 1.6 M, ACTH 7-38 3.2 M, bovine
insulin 4.8 M, and bovine ubiquitin 4.8 M in H2O)
and a polyethylene glycol (PPG-2000). The spatial res-
olution (determined by the laser spot size) of the Bruker
Ultraflex instrument was 75 m, while the Synapt
spatial resolution was 150 m. FlexImaging ver. 2.0
software (Bruker Daltonik GmbH, Bremen, Germany)
and Biomap (Novartis, Basel, Switzerland) were used
for image reconstruction. Around 13,000 irradiated po-
Figure 2. Mass spectra of digested FFPE tiss
corresponding drift scope from MALDI-Ion mo
driftscope (d) shows isobaric ions with differ
corresponds to the 3-dimension visualization o
time inside the ion mobility cell.sitions are recorded for a full brain tissue with 800 laser
shots per position. The software (Biomap and FlexImag-
ing) measures an average mass spectrum at each position
on the tissue section.
MALDI MS/MS with Ion Mobility
MALDI MS/MS was performed with the Synapt
MALDI ion mobility-TOF with the same ion mobility
parameters as described in the previous section, per-
formed in the last part of the T-wave called the “transfer
a) and zoomed around 1040 m/z (b) and the
y mass spectrometry (c). A zoomed area in the
rift times in the circled areas. The driftscope
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between 75 and 85 eV. Protein identification was per-
formed with MASCOT sequence query search program
using the SwissProt database restricted to the taxonomy
“Rattus norvegicus” for FFPE tissue and “Homo sapi-
ens” for frozen tissue. A tolerance of 20 ppm for peptide
and 0.1 Da for MS/MS was set.
Results and Discussion
Sample Preparation
Figure 1 presents the IMS workflow used herein. Sam-
ple sections were submitted to different washing steps,
Figure 3. These images show the ability to
spectrometry. Two examples show separations o
Two isobaric ions of 760 m/z from frozen cerebell
from FFPE cerebellum tissue (framed). Even if t
identified by selecting their specific drift time (imageas described in the Experimental section, to avoid
formation of salt adducts and in general to reduce ion
suppression effects. In the case of FFPE tissues, samples
were dewaxed [47] with baths of xylene or toluene and
a dilution series of ethanol bathes. The dewaxing and
hydration steps are very crucial to have a hydrophilic
sample, which can easily incorporate trypsin solution.
For frozen samples, chloroform was used to remove
lipids and consequently facilitate MS/MS identifica-
tions of low mass peptides. A trypsin digestion protocol
was then applied to FFPE and frozen tissue sections for
the identification of peptides and proteins in tissue.
Trypsin was spotted on-tissue and digestion was fol-
rate digested peptides by ion mobility mass
s by ion mobility according their drift time (a).
issue (framed) (b). Two isobaric ions of 1039 m/z
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nate salts from the trypsin buffer solution. Afterwards,
matrix was deposited on the tissue. The digestion
process was performed so the spatial distribution of
compounds on the digested tissue surface would be
retained. The homogeneity of both trypsin and matrix
layers is ensured by reproducible mechanical deposition.
The comparison between digested tissue and control
tissue (Figure 1d and e) shows large differences in terms of
number of detected peaks in the peptide mass range. The
sample preparation seems to be a crucial step for detection
sensitivity and efficient reproducibility of analysis. In this
experiment, trypsin and matrix were spotted on top of
sample surface. These steps increase the risk of delocalization
of peptides. Therefore, reproducible and robust techniques
are needed to overcome these delocalization problems.
Digested Sample Analysis
On-tissue digestion results in a large number of peaks
as observed in Figure 2a, especially in the mass range
400–2500 m/z. Figure 2b shows a zoom inset where a
large number of peaks are observed in a small mass
range (1–2 Da). The large number of peptides results in
an elevated baseline level and peaks without any isoto-
pic profile. This large number of peptides cannot be
discriminated and selected individually for MS/MS
identification by classic mass selection criterion in, e.g.,
MALDI-TOF/TOF instruments. Two solutions for com-
plicated mass spectra, such as those shown in Figure 2,
can be envisaged. A high resolution mass spectrometer
such as FT-MS can be used or a gas-phase ion mobility
separation before mass analysis can be added.
MALDI-ion mobility MS brings an added value to
MALDI-MS tissue imaging by the separation of differ-
ent compounds families such as lipids and proteins [44,
46]. The ion mobility cell, positioned between a quad-
Figure 4. MALDI Imaging of different compo
separation (Biomap software).rupole and a time-of-flight analyzer, allows the separa-
tion of isobaric compounds or compounds with similar
m/z, which cannot be separated by single mass criterion.
Different ion conformations have different ion cross-
sections and result in different drift times. This particular
property is comparable to liquid chromatography separa-
tion and allows the separation and identification of chem-
ical families such as matrix, drugs, lipids, and single or
double charged peptide ions by their retention time inside
the ion mobility cell. As observed in the average mass
spectra of a FFPE brain section measured with MALDI-
IM-MS in Figure 2a, many compounds have similar m/z,
but it is possible to discriminate between them by their
drift time (Figure 2c and d). Figure 2c shows the driftscope
corresponding to the 3D visualization of detected signals.
The mass scale (m/z) is the y axis, the drift time is the x
axis, and the color scale representing the signal intensity
constitutes the third dimension of the driftscope. Zooming
on the driftscope shows isobaric ions with different drift
times (circled, Figure 2d). The added drift time dimension
(a rapid separation in the gas phase) is used to differenti-
ate isobaric peptides from different proteins, for imaging
MS experiments, and to identify them by tandemMSwith
high confidence using a combination ofm/z and drift time
selection criteria.
Drift Time Separation and MS Experiment in
Digested Tissue
In MS mode, without any selection in the quadrupole,
ions are detected as observed in the mass spectrum
(Figure 2a) and in the corresponding drift scope (Figure
2c). Many peaks are observed with different drift times
but an identical nominal mass over charge ratio. Figure
3a and b illustrate the drift time separation of several
isobaric m/z peaks. The time-resolved drift time separa-
in FFPE (a) and frozen (b) with ion mobilityunds
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reconstructing images, which allows mass and drift
time selected ion images as shown in Figure 4. Isobaric
ions can be distributed differently on-tissue, but mass
selected ion images would display the overlaid image
with contributions from every isobaric ion. Time sepa-
ration enables the deconvolution of this image and
reveals single compound-specific localization on-tissue.
This example illustrates how ion mobility differentiates
a large number of isobaric molecules by their IM
retention time. MALDI-IM-IMS proves capable to de-
tect and localize many more compounds than a classic
MALDI-IMS experiment. Approximately 25% more
peaks (many of which are peptides) have been detected
with the addition of ion mobility separation. IM greatly
enhances the detection sensitivity in MALDI-MS and
increases the biological application potentials of IMS.
Figure 5. A. Mass spectra of fragmented pepti
of separation of MS/MS ions are presented (760 andProteins MS/MS Identification of Peptides Fragments
Figure 5 shows two examples of MS/MS analysis of
mass and time selected parent ions. Both parent ions
mass-selected at m/z 760 and 1039 ions present two drift
time maxima corresponding to at least two different
isobaric ions. Collision induced dissociation (CID) is
performed in the transfer cell in the last part of the
tri-wave mobility cell. Isobaric ions are first separated
then fragmented inside the transfer cell followed by
mass analysis in the orthogonal-TOF. As a consequence,
the drift time separation is conserved after dissociation
and all fragment ions with similar retention time orig-
inate from the same parent. The ion selection window is
kept relatively large (1 Da) to maintain enough sensi-
tivity. The m/z 760 isobaric ions are presented in Figure
5 together with the associated MS/MS drift scope. Two
different isobaric ions and their fragments were de-
y MALDI-Ion mobility MS/MS. Two examplesdes b
1039 m/z).
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ments when the drift-time criterion is selected. Without
the ion mobility separation, the tandem MS analysis
could be misleading and the ion identified as a lipid
(data not shown). However, the fragmentation pattern
of isobaric ions (m/z 760) appears different when sepa-
rated by ion mobility (Figure 5). The characteristic
observed fragment ions with m/z 184 and 175 demon-
strate simultaneous presence of a lipid and a peptide. In
a classic tandem MS scheme, the intensity difference
between these two compounds would not allow the
conclusive determination of the presence of the peptide.
The second example in the bottom half of figure 5
illustrates the possibility to separate and identify two
compounds within the same chemical family, where
two ipeptides show unique fragmentation patterns after
ion mobility separation. The spatial distribution of these
ion mobility separated and fragmented peptides are
shown in the images in Figure 6.
The MALDI-IM-IMS geometry allows the a posteri-
ori separation with the drift time, where the fragments
come from different parent ions. Each isobaric ion that
can be observed and separated in IM-MS mode can be
subjected to specific tandem-MS analysis and give its
own proper fragment ion spectrum.
Mascot Score
The ability to separate isobaric ions with IM and,
therefore, to separate fragmentation profiles of different
ions enables a high specificity database search by pool-
ing fragments associated to only one parent. The com-
parison between Mascot scores with and without drift
time fragment pooling shows the power of the added
IMS separation (data not shown). The score increases
dramatically by a factor of five to six when ion mobility-
specific fragmentation profiles are taken into account
for database search. Thus, fragmentation profiles orig-
inating from ions with m/z 1039 separated by ion
mobility are submitted to separate Mascot database
Figure 6. Images of separated and identifie
fragments (1039 m/z) are presented directly on
(Biomap software). For these images, two diff
133–148 bins to reconstruct the respective imag
corresponding to the superposition of these two imasearches and lead to identification of two different
peptides from two different proteins: tubulin and ubiq-
uitin. Tubulin protein is identified with a high score
whereas ubiquitin gets a lower score. However, without
ion mobility separation, the Mascot score is too low and
insignificant and does not allow the identification of
these proteins. The ion mobility separation combined
with MALDI MS/MS instrument increases the number
of identified peptides by simplifying and eliminating
isobaric fragments from different compounds. The ion
mobility also separates lipids and peptides fragments,
allowing the easy identification of phosphocholine PC[12:
0/22:1(13Z)]. The separation of isobaric fragments is the
second added value of ion mobility separation. The
combination of the two added values of ion mobility,
characterized by the differential identification and dif-
ferential imaging of isobaric ions, brings MALDI imag-
ing MS a step further in the field of proteomics, en-
abling imaging of identified proteins and lipids.
Conclusion
The addition of IM to the MALDI-MS experiment adds
a powerful separation dimension, which provides more
insight into an MS dataset. In this article, this is illus-
trated with mass and time selected ion images repre-
senting specific tissue distributions for different isobaric
tryptic peptides. However, this ability to separate iso-
baric ions can also be applied to peptide identification.
Drift time separation of isobaric parent ions enables
observation of specific fragmentation patterns, which
results in higher databases search scores and higher
confidence of peptides and proteins identification. This
is especially useful for the analysis of digested tissues
where spectra are very complex in the peptide mass
range. This results in numerous peptides isotopic pat-
tern overlaps and multiple unresolved peaks at a single
nominal mass. IM coupled to tandem MS within an
imaging mass spectrometry context results in the deter-
mination of accurate and relevant spatial distributions
baric ions of Tubulin and ubiquitin peptide
e by ion mobility mass spectrometry imaging
drift times have been selected: 100–127 and
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tides. Different proteins identified, based on tandem
MS of isobaric ions, display different tissue localization.
This proves that IMS enhances the MALDI molecular
imaging capabilities, especially by performing some
peptides identification directly on-tissue. Therefore, this
approach could become, in a near future, a tool for
bottom-up proteomics.
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